EAS Newsletter November 25, 2025
Society:
Young Investigator Awards for outstanding publications, call for nominations opens
With these annual Young Investigator Awards for outstanding publications, EAS recognizes excellence that contributes to advancing knowledge in the field of atherosclerosis and related metabolic disturbances.
The call for nominations will open December 1, 2025 until February 2, 2026. Results will be announced in March 2026.
Two recipients (one in basic science and one in clinical research) will each receive a prize of €2000. The award ceremony will take place during the Opening Ceremony of the EAS Congress.
Read the criteria for nominations now:
Learn more about the nomination procedurePublications:
Editor’s Choice – November 2025
Atherosclerosis proudly presents four outstanding papers selected as this month’s Editor’s Choice, showcasing innovative advances in lipid research and cardiovascular disease.
Leading this selection is John Chapman and Chris Packard et al., with the inaugural Expert State-of-the-Art Review: “Triglyceride-rich lipoproteins, remnants, and atherosclerotic cardiovascular disease: What we know and what we need to know.” This new article type delivers an authoritative synthesis of current evidence, identifies key knowledge gaps, and outlines priorities for future research in the field of TRL/remnant lipoproteins and residual risk.
Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know
We also highlight three outstanding original studies:
Atherogenic responsibility of lipoprotein (a) and other apolipoprotein B-containing lipoproteins in acute coronary syndrome
Antonio Meseguer-Hernandez et al. “Atherogenic responsibility of lipoprotein (a) and other apolipoprotein B-containing lipoproteins in acute coronary syndrome”. This study provides new insights into the relative atherogenic impact of Lp(a) versus other apoB-containing lipoproteins in acute coronary syndrome patients. Importantly, a predominance of Lp(a)-driven atherogenicity is linked to more severe, multivessel coronary artery disease.
Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention
Angelo Oliva et al. “Clinical impact of systemic inflammation across different high-sensitivity C-reactive protein cutoffs in patients undergoing percutaneous coronary intervention”. This large retrospective study evaluates the prognostic value of different hsCRP cutoffs for predicting major adverse cardiovascular events in patients undergoing percutaneous coronary intervention.
Associations between ideal cardiovascular health metrics and lipoprotein subclasses and atherogenic indices: A cross-sectional study of middle-to older-aged adults
Duong T. Luong et al. “Associations between ideal cardiovascular health metrics and lipoprotein subclasses and atherogenic indices: A cross-sectional study of middle-to older-aged adults”. This cross-sectional study investigates the relationships between the AHA’s ideal cardiovascular health (CVH) score and advanced lipoprotein subclass profiles in a cohort of middle- and older-aged adults.
Together, these publications exemplify the scientific excellence and translational impact that define Atherosclerosis.
Education:
Upgrade your knowledge with the latest EAS Webinars
Hear experts break down the EAS Consensus Statement and its innovative framework for addressing obesity-related metabolic disorders. Explore how a three-stage model can guide holistic risk reduction with clear diagnostic criteria and personalised treatment strategies.
To the webinar on-demand
It explores the relationship between ultraprocessed foods and cardiovascular disease (CVD), addresses common misconceptions, and presents evidence-based insights. The session also examines the Nordic dietary pattern – highlighting whole, minimally processed foods – and how it can help reduce CVD risk and support overall cardiovascular health.
Together, these discussions offer a comprehensive understanding of the role diet plays in cardiovascular wellbeing.
Congress:
Throwback to the EAS Congress 2025. Watch all the sessions on EAS Academy
We are pleased to announce that the full recordings from the EAS Congress 2025 are now available on the EAS Academy platform.
Participants can revisit all sessions, lectures, and presentations at their convenience, while those who could not attend the event can now access the complete scientific content online.
Log in to our website & EAS Academy to start exploring the sessions today.
To the EAS Congress 2025 recordingsSociety:
EAS Calendar – November-December 2025
From insightful webinars to groundbreaking announcements, this section is your gateway to staying connected and up-to-date with the latest developments within the EAS Society.
November 28, EAS Advanced Course on Rare Lipid Disorders, Germany
December 1, Young Investigator Awards for outstanding publications, call for nominations opens
December 3, EAS Advanced Course on non-classical risk factors, Cambridge, UK
December 4, Young Fellows Meeting
December 4, EAS-SMNE Joint Session at LXV International Congress
December 4-7, 77th Annual Conference of CSI
December 11, LCN National Webinar Guidelines Bosnia & Herzegovina
December 15, Election Committee (ELCOM) online ballot opens